Worried about your investment in InterGlobe Aviation following IndiGo’s recent operational turmoil? HSBC has reassured investors to remain optimistic, stating that despite the recent chaos, the airline’s long-term outlook remains intact. The brokerage acknowledged the significant disruptions but emphasized that the airline’s core fundamentals are still strong, although upcoming quarters may reflect increased costs and operational challenges.
Stock Price Adjustments
In a recent report, HSBC Global Investment Research revised its price target for InterGlobe Aviation, lowering it from Rs 6,920 to Rs 5,977. This adjustment reflects the impact of rising costs, flight cancellations, and currency fluctuations on the airline’s financial performance. Despite this change, HSBC has maintained its ‘Buy’ recommendation for the stock. The firm noted that while IndiGo is currently facing considerable challenges, including mass cancellations and some reputational damage, it continues to hold a competitive cost advantage over its rivals. The brokerage highlighted that IndiGo has canceled approximately 11,000 flights this fiscal year, resulting in an estimated revenue loss of Rs 12–14 billion and a profit reduction of Rs 3–5 billion. Consequently, HSBC has adjusted its EBITDA forecasts for FY26 and FY27 downward by 4% and 5%, respectively.
IndiGo’s Operational Challenges
HSBC pointed out that the airline’s operational crisis was exacerbated by new Flight Duty Time Limitations (FDTL) imposed by the Directorate General of Civil Aviation (DGCA). These updated regulations are stricter than those in the US and Europe, requiring longer rest periods for pilots and limiting night operations. IndiGo, which relies on high aircraft utilization and lean staffing, has been particularly affected, leading to the cancellation of nearly 4,500 flights in just a few days. The brokerage also noted that previous mismanagement in pilot recruitment during IndiGo’s rapid fleet expansion may have contributed to the current operational strain. Compliance with the new regulations could necessitate a significant increase in pilot hiring, potentially adding Rs 450 million to Rs 900 million to staffing costs. The airline’s recent cancellations included over 1,000 flights in a single day, marking a historic low for India’s aviation sector. The DGCA is currently reviewing IndiGo’s explanation for these disruptions and may take enforcement action.
Market Share Concerns
IndiGo’s dominant position in the domestic aviation market has raised concerns among investors about potential government intervention, such as imposing a 50% market-share cap. However, HSBC believes such measures are unlikely, citing the slow growth of competitors like Air India, SpiceJet, and Akasa, which are gradually expanding their fleets. IndiGo continues to receive approximately 50 new aircraft annually, suggesting that a market cap could disrupt overall industry capacity. The brokerage’s analysis indicates that while IndiGo’s market share is substantial, the competitive landscape remains stable, allowing the airline to maintain its leading position.
Signs of Recovery
Despite the recent upheaval, IndiGo is beginning to stabilize its operations. On a recent Monday, the airline successfully operated over 1,800 flights, with on-time performance improving significantly to 91%, up from around 75% the previous day. However, the airline still canceled 562 flights that day, including 150 in Bengaluru. To address the fallout from the disruptions, IndiGo has issued Rs 827 crore in refunds, secured over 9,500 hotel rooms for affected passengers, and arranged transportation for stranded travelers. HSBC remains optimistic about IndiGo’s long-term prospects, asserting that while the recent events have exposed certain weaknesses, such as scheduling and staffing issues, the airline’s overall investment case remains robust. With a significant cost advantage and a slow expansion rate among competitors, IndiGo’s network scale continues to be a critical asset.
Digihunt is not a financial advisor and this is not investment advice.









